Evidence map›Paper›PMID 37669395›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Innate immune responses yield tissue-specific bottlenecks that scale with pathogen dose.

Karthik Hullahalli, Katherine G Dailey, Matthew K Waldor

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. The cholesterol-dependent cytolysin promotesInfection and immunity · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Temporal and spatial dynamics ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Genetic and immune determinants ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Innate immunity decreases pathogen diversity during infection.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Genetic and immune determinants ofbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Karthik HullahalliDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-3064-2090
Katherine G DaileyDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0009-0004-7013-0932
Matthew K WaldorDepartment of Microbiology, Harvard Medical School, Boston, MA 02115.ORCID 0000-0003-1843-7000

Funding

Vibrio cholerae intestinal colonization and vaccine developmentR01AI042347 · NIAID · TUFTS UNIVERSITY BOSTON · PI WALDOR, MATTHEW K · 1998 to 2025
$7.3M
Molecular Biology and Virulence of CTX PhageR37AI042347 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI WALDOR, MATTHEW K · 2008 to 2017
$3.8M
Hepatic survival and population dynamics of extraintestinal pathogenic Escherichia coliF31AI156949 · NIAID · HARVARD MEDICAL SCHOOL · PI HULLAHALLI, KARTHIK · 2021 to 2023
$111k
Howard Hughes Medical InstituteNIAID NIH HHS F31 AI156949NIAID NIH HHS R01 AI042347NIAID NIH HHS R37 AI042347
6 · The paper itself

Abstract

To cause infection, pathogens must overcome bottlenecks imposed by the host immune system. These bottlenecks restrict the inoculum and largely determine whether pathogen exposure results in disease. Infection bottlenecks therefore quantify the effectiveness of immune barriers. Here, using a model of

Indexed as

Escherichia coliEscherichia coli InfectionsHumansImmunity, Innatebottlenecksdose–responseinnate immunitysystemic infection

Identifiers

PMID37669395
PMCPMC10500177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.